Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model

Desislava M. Doycheva, Tiffany Hadley, Li Li, Richard Lee Applegate, John H. Zhang, Jiping Tang

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives: Neonatal hypoxia ischemia (HI) is an injury that can lead to neurological impairments such as behavioral and learning disabilities. Granulocyte-colony stimulating factor (G-CSF) has been demonstrated to be neuroprotective in ischemic stroke however it has also been shown to induce neutrophilia, ultimately exacerbating neuronal injury. Our hypothesis is that coadministration of anti-neutrophil antibody (Ab) with G-CSF will decrease blood neutrophil counts thereby reducing infarct volume and improving neurological function post HI brain injury. Methods: Rat pups were subjected to unilateral carotid artery ligation followed by 2.5. h of hypoxia. Animals were randomly assigned to five groups: Sham (n = 15), vehicle (HI, n = 15), HI with G-CSF treatment (n = 15), HI with G-CSF + Ab treatment (n = 15), and HI with Ab treatment (n = 15). Ab (325 μg/kg) was administered intraperitoneally while G-CSF (50 μg/kg) was administered subcutaneously 1. h post HI followed by daily injections for 3 consecutive days. Animals were euthanized at 96. h post HI for blood neutrophil counts and brain infarct volume measurements as well as at 5. weeks for neurological function testing and brain weight measurements. Lung and spleen weights at both time points were further analyzed. Results: The G-CSF treatment group showed tendencies to reduce infarct volume and improve neurological function while significantly increasing neutrophil counts. On the other hand, the G-CSF + Ab group significantly reduced infarct volume, improved neurological function and decreased neutrophil counts. The Ab alone group showed reversal of the neuroprotective effects of the G-CSF + Ab group. No significant differences were found in peripheral organ weights between groups. Conclusion: Our data suggest that coadministration of G-CSF with Ab not only prevented brain atrophy but also significantly improved neurological function by decreasing blood neutrophil counts. Hence the neuroprotective effects of G-CSF may be further enhanced if neutrophilia is avoided.

Original languageEnglish (US)
Pages (from-to)192-199
Number of pages8
JournalNeurobiology of Disease
Volume69
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Neuroprotective Agents
Granulocyte Colony-Stimulating Factor
Anti-Idiotypic Antibodies
Neutrophils
Ischemia
Antibodies
Brain
Hypoxia
Weights and Measures
Organ Size
Learning Disorders
Wounds and Injuries
Therapeutics
Carotid Arteries
Brain Injuries
Atrophy
Ligation
Spleen
Stroke
Lung

Keywords

  • Anti-neutrophil antibody (Ab)
  • Granulocyte-colony stimulating factor (G-CSF)
  • Hypoxia-ischemia (HI)
  • Neonatal
  • Neurological function
  • Neutrophil

ASJC Scopus subject areas

  • Neurology
  • Medicine(all)

Cite this

Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model. / Doycheva, Desislava M.; Hadley, Tiffany; Li, Li; Applegate, Richard Lee; Zhang, John H.; Tang, Jiping.

In: Neurobiology of Disease, Vol. 69, 2014, p. 192-199.

Research output: Contribution to journalArticle

@article{fe77592e7eeb4cf7a9da4b3034ca58fd,
title = "Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model",
abstract = "Objectives: Neonatal hypoxia ischemia (HI) is an injury that can lead to neurological impairments such as behavioral and learning disabilities. Granulocyte-colony stimulating factor (G-CSF) has been demonstrated to be neuroprotective in ischemic stroke however it has also been shown to induce neutrophilia, ultimately exacerbating neuronal injury. Our hypothesis is that coadministration of anti-neutrophil antibody (Ab) with G-CSF will decrease blood neutrophil counts thereby reducing infarct volume and improving neurological function post HI brain injury. Methods: Rat pups were subjected to unilateral carotid artery ligation followed by 2.5. h of hypoxia. Animals were randomly assigned to five groups: Sham (n = 15), vehicle (HI, n = 15), HI with G-CSF treatment (n = 15), HI with G-CSF + Ab treatment (n = 15), and HI with Ab treatment (n = 15). Ab (325 μg/kg) was administered intraperitoneally while G-CSF (50 μg/kg) was administered subcutaneously 1. h post HI followed by daily injections for 3 consecutive days. Animals were euthanized at 96. h post HI for blood neutrophil counts and brain infarct volume measurements as well as at 5. weeks for neurological function testing and brain weight measurements. Lung and spleen weights at both time points were further analyzed. Results: The G-CSF treatment group showed tendencies to reduce infarct volume and improve neurological function while significantly increasing neutrophil counts. On the other hand, the G-CSF + Ab group significantly reduced infarct volume, improved neurological function and decreased neutrophil counts. The Ab alone group showed reversal of the neuroprotective effects of the G-CSF + Ab group. No significant differences were found in peripheral organ weights between groups. Conclusion: Our data suggest that coadministration of G-CSF with Ab not only prevented brain atrophy but also significantly improved neurological function by decreasing blood neutrophil counts. Hence the neuroprotective effects of G-CSF may be further enhanced if neutrophilia is avoided.",
keywords = "Anti-neutrophil antibody (Ab), Granulocyte-colony stimulating factor (G-CSF), Hypoxia-ischemia (HI), Neonatal, Neurological function, Neutrophil",
author = "Doycheva, {Desislava M.} and Tiffany Hadley and Li Li and Applegate, {Richard Lee} and Zhang, {John H.} and Jiping Tang",
year = "2014",
doi = "10.1016/j.nbd.2014.05.024",
language = "English (US)",
volume = "69",
pages = "192--199",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model

AU - Doycheva, Desislava M.

AU - Hadley, Tiffany

AU - Li, Li

AU - Applegate, Richard Lee

AU - Zhang, John H.

AU - Tang, Jiping

PY - 2014

Y1 - 2014

N2 - Objectives: Neonatal hypoxia ischemia (HI) is an injury that can lead to neurological impairments such as behavioral and learning disabilities. Granulocyte-colony stimulating factor (G-CSF) has been demonstrated to be neuroprotective in ischemic stroke however it has also been shown to induce neutrophilia, ultimately exacerbating neuronal injury. Our hypothesis is that coadministration of anti-neutrophil antibody (Ab) with G-CSF will decrease blood neutrophil counts thereby reducing infarct volume and improving neurological function post HI brain injury. Methods: Rat pups were subjected to unilateral carotid artery ligation followed by 2.5. h of hypoxia. Animals were randomly assigned to five groups: Sham (n = 15), vehicle (HI, n = 15), HI with G-CSF treatment (n = 15), HI with G-CSF + Ab treatment (n = 15), and HI with Ab treatment (n = 15). Ab (325 μg/kg) was administered intraperitoneally while G-CSF (50 μg/kg) was administered subcutaneously 1. h post HI followed by daily injections for 3 consecutive days. Animals were euthanized at 96. h post HI for blood neutrophil counts and brain infarct volume measurements as well as at 5. weeks for neurological function testing and brain weight measurements. Lung and spleen weights at both time points were further analyzed. Results: The G-CSF treatment group showed tendencies to reduce infarct volume and improve neurological function while significantly increasing neutrophil counts. On the other hand, the G-CSF + Ab group significantly reduced infarct volume, improved neurological function and decreased neutrophil counts. The Ab alone group showed reversal of the neuroprotective effects of the G-CSF + Ab group. No significant differences were found in peripheral organ weights between groups. Conclusion: Our data suggest that coadministration of G-CSF with Ab not only prevented brain atrophy but also significantly improved neurological function by decreasing blood neutrophil counts. Hence the neuroprotective effects of G-CSF may be further enhanced if neutrophilia is avoided.

AB - Objectives: Neonatal hypoxia ischemia (HI) is an injury that can lead to neurological impairments such as behavioral and learning disabilities. Granulocyte-colony stimulating factor (G-CSF) has been demonstrated to be neuroprotective in ischemic stroke however it has also been shown to induce neutrophilia, ultimately exacerbating neuronal injury. Our hypothesis is that coadministration of anti-neutrophil antibody (Ab) with G-CSF will decrease blood neutrophil counts thereby reducing infarct volume and improving neurological function post HI brain injury. Methods: Rat pups were subjected to unilateral carotid artery ligation followed by 2.5. h of hypoxia. Animals were randomly assigned to five groups: Sham (n = 15), vehicle (HI, n = 15), HI with G-CSF treatment (n = 15), HI with G-CSF + Ab treatment (n = 15), and HI with Ab treatment (n = 15). Ab (325 μg/kg) was administered intraperitoneally while G-CSF (50 μg/kg) was administered subcutaneously 1. h post HI followed by daily injections for 3 consecutive days. Animals were euthanized at 96. h post HI for blood neutrophil counts and brain infarct volume measurements as well as at 5. weeks for neurological function testing and brain weight measurements. Lung and spleen weights at both time points were further analyzed. Results: The G-CSF treatment group showed tendencies to reduce infarct volume and improve neurological function while significantly increasing neutrophil counts. On the other hand, the G-CSF + Ab group significantly reduced infarct volume, improved neurological function and decreased neutrophil counts. The Ab alone group showed reversal of the neuroprotective effects of the G-CSF + Ab group. No significant differences were found in peripheral organ weights between groups. Conclusion: Our data suggest that coadministration of G-CSF with Ab not only prevented brain atrophy but also significantly improved neurological function by decreasing blood neutrophil counts. Hence the neuroprotective effects of G-CSF may be further enhanced if neutrophilia is avoided.

KW - Anti-neutrophil antibody (Ab)

KW - Granulocyte-colony stimulating factor (G-CSF)

KW - Hypoxia-ischemia (HI)

KW - Neonatal

KW - Neurological function

KW - Neutrophil

UR - http://www.scopus.com/inward/record.url?scp=84902656270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902656270&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2014.05.024

DO - 10.1016/j.nbd.2014.05.024

M3 - Article

C2 - 24874543

AN - SCOPUS:84902656270

VL - 69

SP - 192

EP - 199

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -